Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives
Abstract Background The majority of individuals with opioid use disorder (OUD) face access barriers to evidence-based treatment, and the COVID-19 pandemic has exacerbated the United States (US) opioid overdose crisis. However, the pandemic has also ushered in rapid transitions to telehealth in the U...
Guardado en:
Autores principales: | Shoshana V. Aronowitz, Eden Engel-Rebitzer, Abby Dolan, Kehinde Oyekanmi, David Mandell, Zachary Meisel, Eugenia South, Margaret Lowenstein |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ba23710e49064ce08956bfc5f116a214 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Expediting telehealth use in clinical research studies: recommendations for overcoming barriers in North America
por: Anna Naito, et al.
Publicado: (2021) -
Clinician-scientists in Canada: barriers to career entry and progress.
por: Bryn Lander, et al.
Publicado: (2010) -
Inclusive innovation in telehealth
por: Kimberly Noel, et al.
Publicado: (2020) -
Telehealth initiatives in Brazil
por: Coury, Wilson, et al.
Publicado: (2014) -
The National Telemedicine and Telehealth Programme in Panama
por: Vega, Silvio
Publicado: (2014)